Castlight Health, inc. (NYSE:CSLT) President Robert Derek Newell acquired 30,468 shares of Castlight Health, inc. stock in a transaction that occurred on Wednesday, November 1st. The stock was acquired at an average cost of $3.95 per share, with a total value of $120,348.60. Following the purchase, the president now owns 128,671 shares in the company, valued at approximately $508,250.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Robert Derek Newell also recently made the following trade(s):

  • On Friday, October 27th, Robert Derek Newell acquired 30,000 shares of Castlight Health, inc. stock. The stock was acquired at an average cost of $3.95 per share, with a total value of $118,500.00.

Castlight Health, inc. (NYSE:CSLT) last released its earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. The business had revenue of $34.60 million during the quarter, compared to the consensus estimate of $34.61 million. Castlight Health, inc. had a negative net margin of 45.14% and a negative return on equity of 32.57%. The firm’s revenue for the quarter was up 35.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.05) earnings per share.

TRADEMARK VIOLATION WARNING: This piece was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/02/castlight-health-inc-cslt-president-buys-120348-60-in-stock.html.

Several research firms recently issued reports on CSLT. Dougherty & Co reaffirmed a “buy” rating on shares of Castlight Health, inc. in a research note on Thursday, August 17th. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $5.00 price objective on shares of Castlight Health, inc. in a research note on Wednesday, October 25th. BidaskClub lowered shares of Castlight Health, inc. from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. ValuEngine raised shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Castlight Health, inc. in a research note on Thursday, October 26th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $5.22.

Institutional investors have recently added to or reduced their stakes in the stock. Voya Investment Management LLC grew its position in Castlight Health, inc. by 25.4% in the second quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock valued at $112,000 after purchasing an additional 5,453 shares in the last quarter. Stifel Financial Corp grew its position in Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock valued at $133,000 after purchasing an additional 1,500 shares in the last quarter. Nationwide Fund Advisors grew its position in Castlight Health, inc. by 49.5% in the second quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock valued at $151,000 after purchasing an additional 12,061 shares in the last quarter. UBS Asset Management Americas Inc. bought a new position in Castlight Health, inc. in the second quarter valued at $193,000. Finally, Edge Wealth Management LLC grew its position in Castlight Health, inc. by 6.5% in the second quarter. Edge Wealth Management LLC now owns 50,050 shares of the software maker’s stock valued at $198,000 after purchasing an additional 3,050 shares in the last quarter. 41.29% of the stock is owned by institutional investors and hedge funds.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.